Generation of Oligodendrocytes from Human Pluripotent and Embryonic Stem Cells.
Z. Mattingly, S. Chetty. (2023)
Methods in Molecular Biology. 2023;2683:89-101. doi.10.1007/978-1-0716-3287-1_8. PMID: 37300769. [book chapter]

The CD22-IGF2R interaction is a therapeutic target for microglial lysosome dysfunction in Niemann-Pick Type C.
J. Pluvinage, J. Sun, C. Claes, R. A. Flynn, M. S. Haney, T. Iram, X. Meng, R. Lindemann, N. M. Riley, E. Danhash, J. P. Chadarevian, E. Tapp, D. Gate, I. Cobos, S. Chetty, A. Pasca, S. Pasca, E. Berry-Kravis, C. R. Bertozzi, M. Blurton-Jones, T. Wyss-Coray. (2021)
Science Translational Medicine, 13 (622). [paper]

Overexpression of CD47 is associated with brain overgrowth and 16p11.2 deletion syndrome.
J. Li, T. Brickler, A. Banuelos, K. Marjon, A. Shcherbina, S. Banerjee, J. Bian, C. Narayanan, I. Weissman, S. Chetty. (2021)
PNAS, 118 (15) e2005483118. [paper]

To eat, or not to eat, that is the question: Neural stem cells escape phagocytosis in autism with macrocephaly.
S. Schafer and F.H. Gage. (2021)
PNAS, 118 (19) e2104888118. [commentary]
Autism mutation may cause big brain via ‘don’t eat me’ signals by Spectrum News and CD47 and autism by Stanford's Institute for Stem Cell Biology and Regenerative Medicine [press coverage]

Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-oligodendrocyte Interactions.
B. Assetta, C. Tang, J. Bian, T. Brickler, S. Chetty, Y. Huang. (2020)
J. Vis. Exp. doi: 10.3791/61778. [paper]

Variations and expression features of CYP2D6 contribute to schizophrenia risk. Mol Psychiatry.
Ma, L., Shcherbina, A. & Chetty, S. (2020)
Molecular Psychiatry, 26, pages 2605–2615 (2021) [paper]

Cell cycle dynamics of human pluripotent stem cells primed for differentiation.
A. Shcherbina, J. Li, C. Narayanan, W. Greenleaf, A. Kundaje, S. Chetty. (2019)
Stem Cells, 00: 1-7. [paper]

Transient treatment of human pluripotent stem cells with DMSO to promote differentiation.
D. Sambo, J. Li, T. Brickler, and S. Chetty. (2019)
J. Vis. Exp. (149), e59833, doi:10.3791/59833. [paper]

A transient DMSO treatment increases the differentiation potential of human pluripotent stem cells through the Rb family.
J. Li, C. Narayanan, J. Bian, D. Sambo, T. Brickler, W. Zhang, S. Chetty. (2018)
PLoS ONE 13(12): e0208110. [paper]

A qPCR ScoreCard quantifies the differentiation potential of human pluripotent stem cells.
A.M. Tsankov, V. Akopian, R. Pop, S. Chetty, C.A. Gifford, L. Daheron, N.M. Tsankova, A. Meissner. (2015)
Nature Biotechnology 33: 1182-1192. [paper]

A Src inhibitor regulates the cell cycle of human pluripotent stem cells and improves directed differentiation.
S. Chetty*, E.N. Engquist, E. Mehanna, K.O. Lui, A.M. Tsankov, D.A. Melton*. (2015)
*co-corresponding author
The Journal of Cell Biology 210: 1257-1268 [paper] [non-technical summary]

A simple tool to improve pluripotent stem cell differentiation.
S. Chetty, F.W. Pagliuca, C. Honore, A. Kweudjeu, A. Rezania, D.A. Melton. (2013)
Nature Methods 10: 553-556. [paper]

Stress and glucocorticoids promote oligodendrogenesis in the adult hippocampus.
S. Chetty, A.R. Friedman, K. Taravosh-Lahn, E.D. Kirby, C. Mirescu, F. Guo, D. Krupik, A. Nicholas, A. Geraghty, A. Krishnamurthy, M. Tsai, D. Covarrubias, A. Wong, D. Francis, R.M. Sapolsky, T.D. Palmer, D. Pleasure, D. Kaufer. (2014) Molecular Psychiatry 19: 1275-1283. [paper] [press coverage]

Altered prefrontal function with aging: insights into age-associated performance decline.
A.K. Solbakk, G.F. Alpert, A.J. Furst, L.A. Hale, T. Oga, S. Chetty, N. Pickard, R.T. Knight. (2008)
Brain Research1232: 30-47. [paper]

11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration.
G.D. Rabinovici, A.J. Furst, J.P. O'Neil, C.A. Racine, E.C. Mormino, S.L. Baker, S. Chetty, P.Patel, T.A. Pagliaro, W.E. Klunk, C.A. Mathis, H.J. Rosen, B.L. Miller, W.J. Jagust. (2007)
Neurology 68:1205-1212. [paper]